Recently, Qilu Pharmaceutical Group welcomed Lu Lin, academician of the Chinese Academy of Sciences and president of Shandong First Medical University, and his party visited and investigated, Li Yan, president of Qilu Pharmaceutical Group, and Zhang Minghui, vice president of Qilu Pharmaceutical Group and president of the Institute of Materia Medica, accompanied the investigation, and introduced the operation and management of the enterprise and the corporate culture in depth
.
Li Yan, President of Qilu Pharmaceutical Group, expressed a warm welcome to the arrival of Lu Lin and his party, accompanied by Lu Lin and his party, Lu Lin and his party visited the exhibition hall of Qilu Pharmaceutical Enterprise, CMC R&D platform and intelligent manufacturing production workshop, and deeply and comprehensively understood the development process, industrial layout, corporate culture construction, drug research and development of the
enterprise.
At the subsequent symposium, Li Yan introduced the operation and management of Qilu Pharmaceutical to the research group
.
After Li Yan ended his speech, Lu Lin expressed his high appreciation
for the high-quality development of Qilu Pharmaceutical and its strong feelings of home and country.
It is understood that Qilu Pharmaceutical has invested heavily in scientific and technological innovation and talent training, with R&D investment of up to 3.
In the future, it is expected that Qilu Pharmaceutical and Shandong First Medical University will establish an in-depth cooperation mechanism for talent training and technical exchanges, open up bottlenecks and blockages in the integration of industrial and educational development, and benefit
more people.
Recently, Qilu Pharmaceutical Group welcomed Lu Lin, academician of the Chinese Academy of Sciences and president of Shandong First Medical University, and his party visited and investigated, Li Yan, president of Qilu Pharmaceutical Group, and Zhang Minghui, vice president of Qilu Pharmaceutical Group and president of the Institute of Materia Medica, accompanied the investigation, and introduced the operation and management of the enterprise and the corporate culture in depth
.
Li Yan, President of Qilu Pharmaceutical Group, expressed a warm welcome to the arrival of Lu Lin and his party, accompanied by Lu Lin and his party, Lu Lin and his party visited the exhibition hall of Qilu Pharmaceutical Enterprise, CMC R&D platform and intelligent manufacturing production workshop, and deeply and comprehensively understood the development process, industrial layout, corporate culture construction, drug research and development of the
enterprise.
At the subsequent symposium, Li Yan introduced the operation and management of Qilu Pharmaceutical to the research group
.
After Li Yan ended his speech, Lu Lin expressed his high appreciation
for the high-quality development of Qilu Pharmaceutical and its strong feelings of home and country.
It is understood that Qilu Pharmaceutical has invested heavily in scientific and technological innovation and talent training, with R&D investment of up to 3.
In the future, it is expected that Qilu Pharmaceutical and Shandong First Medical University will establish an in-depth cooperation mechanism for talent training and technical exchanges, open up bottlenecks and blockages in the integration of industrial and educational development, and benefit
more people.
Recently, Qilu Pharmaceutical Group welcomed Lu Lin, academician of the Chinese Academy of Sciences and president of Shandong First Medical University, and his party visited and investigated, Li Yan, president of Qilu Pharmaceutical Group, and Zhang Minghui, vice president of Qilu Pharmaceutical Group and president of the Institute of Materia Medica, accompanied the investigation, and introduced the operation and management of the enterprise and the corporate culture in depth
.
Li Yan, President of Qilu Pharmaceutical Group, expressed a warm welcome to the arrival of Lu Lin and his party, accompanied by Lu Lin and his party, Lu Lin and his party visited the exhibition hall of Qilu Pharmaceutical Enterprise, CMC R&D platform and intelligent manufacturing production workshop, and deeply and comprehensively understood the development process, industrial layout, corporate culture construction, drug research and development of the
enterprise.
At the subsequent symposium, Li Yan introduced the operation and management of Qilu Pharmaceutical to the research group
.
After Li Yan ended his speech, Lu Lin expressed his high appreciation
for the high-quality development of Qilu Pharmaceutical and its strong feelings of home and country.
It is understood that Qilu Pharmaceutical has invested heavily in scientific and technological innovation and talent training, with R&D investment of up to 3.
32 billion yuan in 2021, and drug innovation is also fruitful, at present, 109 products have passed the consistency evaluation, 44 are the first in China, all ranking first in the industry; In terms of school-enterprise cooperation and talent training, Qilu Pharmaceutical has been committed to promoting the in-depth integration of production, education and research, and has cooperative relations with many universities and research institutes, realizing the seamless docking of enterprises and scientific research institutes, science and technology and industry, and providing better treatment options
for more patients.
In the future, it is expected that Qilu Pharmaceutical and Shandong First Medical University will establish an in-depth cooperation mechanism for talent training and technical exchanges, open up bottlenecks and blockages in the integration of industrial and educational development, and benefit
more people.
